ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc.
AVTE
時価総額
$5672.1万
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2021年
12月31日
2022年
12月31日
Net loss
-23
-52
Stock-based compensation expense
2
5
Depreciation and amortization expense
0
0
Accretion of discounts and amortization of premiums on investments, net
0
-1
Prepaid expenses and other current assets
7
-5
Other long-term assets
0
2
Accounts payable
1
1
Accrued and other liabilities
-0
4
Operating lease assets and liabilities, net
-
0
Other liabilities
0
-0
Net cash used in operating activities
-27
-39
Purchases of short-term investments
-
148
Sales and maturities of short-term investments
-
155
Purchases of property and equipment
0
0
Net cash provided by (used in) investing activities
-113
7
Proceeds from sale of Series A redeemable convertible preferred stock, net of issuance costs
64
-
Payments for deferred offering costs
-
0
Proceeds from issuance of common stock under ESPP
-
0
Proceeds from exercise of stock options
-
1
Proceeds from issuance of common stock, net of issuance costs
127
-
Net cash provided by financing activities
190
0
Net (decrease) increase in cash and cash equivalents
50
-32
Right-of-use asset obtained in exchange for operating lease liability
1
1
Deferred offering costs included in accounts payable
-
0
Purchases of property and equipment in accounts payable
0
-